Trials / Completed
CompletedNCT03052491
Effects of a 10 Component Dietary Supplement on Health and the Quality of Life
Effects of a Multi-Pathway Dietary Supplement (Stem Cell 100+) on Indices of Health and Life Expectancy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Centagen, Inc. · Industry
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This open-label field trial evaluates the effects of treatment with a multi-pathway dietary supplement (Stem Cell 100+) that has been commercially available for several years. The objective of the intervention trial is to determine if normal subjects over 35 years of age experience any observable health benefits from the dietary supplement as to their blood pressure, pulse rate, blood cholesterol, lung capacity, stress levels, or self reported changes in markers of overall health and life expectancy.
Detailed description
Currently, only dietary restriction has been verified to slow the rate of aging and to promote general health. This trial is designed to see whether a complex supplement (Stem Cell 100+) that targets multiple longevity pathways could also have positive effects on several markers of successful aging and good health. Multipath causes of aging include: stem cell function, telomere loss, chronic stress, inflammation, insulin-like growth factors, autophagy, vascular loss, neural dysfunction, and oxidative stress. The goal of the study was to test the effects of this novel multipath intervention strategy in a clinical trial of healthy people using health markers such as blood pressure, cholesterol status, lung function, stress levels, and self-reported health status. Hundreds of published animal and human clinical studies have been done with each of the individual active ingredients in the formulation, which target many critical causes of aging. Based on their published animal studies showing extension of life span in a model animal and their laboratory work on adult human stem cells, the investigators believe that Stem Cell 100+ will provide evidence of efficacy in addressing multiple index markers of health and life expectancy outcomes.
Conditions
- Blood Pressure
- HDL Low
- Stress
- Lung Function Decreased
- Quality of Life
- Energy Supply; Deficiency
- Concentration Ability Impaired
- Joint Instability
- Immune Deficiency
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Stem Cell 100+ | Open-Label 10-Component Dietary Supplement |
Timeline
- Start date
- 2016-03-12
- Primary completion
- 2016-08-24
- Completion
- 2016-08-24
- First posted
- 2017-02-14
- Last updated
- 2017-02-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03052491. Inclusion in this directory is not an endorsement.